Authors
Latest:
SDNP President Amanda Caldwell, MSN, APRN-C, on Empowering NPs Through Enhanced Support and EducationAmanda Caldwell, MSN, APRN-C, is fostering community and collaboration for NPs and PAs as the new president of the SDNP.
Latest:
Take-Home PointsJoshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
Latest:
Anti-Cancer Immunotherapy Treatments Spark Common Skin-Related ToxicitiesDermatologist Laura Ferris, MD, PhD, discusses skin-related toxicities as a result of immunotherapies for the treatment and management of cancers.
Latest:
Best Practices for Recruiting Talented Staff for Your PracticeMedical practices must go beyond simply offering competitive salaries and benefits packages to attract new talent and keep their best clinicians and administrative staff working for them.
Latest:
Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician PerspectivesPatient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.
Latest:
No Kidding: Tips for Treating Pediatric ADWhat are the special considerations for treating pediatric atopic dermatitis? Test your knowledge and hear more from an expert.
Latest:
Looking Ahead to Povorcitininb for HS and the Availability of Generic TofacitinibAt RAD 2025, Matthew Zirwas, MD, outlined 2 upcoming shifts in dermatology: the emergence of povorcitinib for hidradenitis suppurativa and the anticipated generic availability of tofacitinib.
Latest:
Q&A: Laura Scott, MD, FAAD, and Sun Bum on the Road to Accessible Sun SafetySun safety awareness grows with Laura Scott, MD, FAAD, and Sun Bum's "Trust the Bum Tour," offering free SPF products and education to diverse communities nationwide.
Latest:
Exploring the Intersection of Permanent Makeup and DermatologyWalter Liszewski, MD, shares insights into discrepancies between permanent makeup and decorative tattoos and which patients may benefit from permanent makeup.
Latest:
Organization Empowers Communities, Individuals to Celebrate the Skin They Are InCelebrating the Skin We're In seeks to advocate for health equity through community outreach and education efforts.
Latest:
Case 2: Female, 15 Years OldDr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options. She also reviews the significance of patient assistance programs in facilitating patient access to and affordability of pharmaceutical therapies.
Latest:
Outgoing AAD President Seemal Desai, MD, FAAD, Reflects on Challenges, Advocacy, and the Future of DermatologyDesai reflects on his AAD presidency, addressing Medicare challenges, technological advancements, and the future of dermatology leadership.
Latest:
Advancing Nail Disorder Care by Bridging Podiatry and DermatologyAt the 2024 SDPA Fall Conference, Tracey Vlahovic, DPM, highlighted the need for interdisciplinary collaboration in nail disorder management, underscoring the importance of mutual learning between podiatry and dermatology.
Latest:
Melanoma Research Foundation and Glowbar Join Forces to Fight Skin CancerIn honor of Melanoma Awareness Month, Glowbar CEO Rachel Liverman spoke to Dermatology Times about this new collaboration, which aims to increase patients' daily sunscreen use by 2026.
Latest:
Impact of Data on Generalized Pustular PsoriasisAaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
Latest:
The Psychosocial Impact of Skin Diseases in ChildrenAcne, molluscum, atopic dermatitis, and other dermatological disorders can be detrimental to quality of life for children and their families.
Latest:
Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s AccessScassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.
Latest:
Unmasking Botulinum Toxin MythsMisleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Latest:
Frontline Forum Part 3: Topical Therapy for Corticosteroid-Responsive DermatosesExperts discuss enhancing patient outcomes, comparing clobetasol cream concentrations, and more.
Latest:
New Biomarker Test Revolutionizes Inflammatory Skin Disease DiagnosisBy leveraging the innovative biomarker panels, clinicians can now offer more personalized and effective treatment options for psoriasis and AD.
Latest:
A Hot Take: The Impact of a Trump Win on U.S. Health CareWith the Affordable Care Act's uncertain future, many Americans are curious about Robert F. Kennedy Jr.'s potential role in the new administration.
Latest:
Beyond Topicals: Surgical Solutions for VitiligoNada Elbuluk, MD, MSc, emphasizes that medical treatments remain first-line for vitiligo, but stable cases may benefit from surgical options.
Latest:
3 Things You Should Know About HS Pathology and ManagementEarn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.
Latest:
“Open Sandwich” Moisturization Regimen Does Not Affect Bioactivity of Retinols and RetinoidsAsha Patel Shah, MD, MBA, FAAD, discusses recent research on retinol and retinoid bioactivity when layered with moisturizers highlighted at AAD 2025.
Latest:
Leukemia-Related Cutaneous FindingsThis review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.
